This resembles the situation in ADA-SCID (12), in which a genetic defect in the ADA1 gene results in increased levels of adenosine and 2’-deoxyadenosine, an early loss of T-, NK- and B-cells and severe immunodeficiency. The gene discussed is ADA; the disease is immunodeficiency disease.